Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Pertuzumab biosimilar by Mabscale for Metastatic Breast Cancer: Likelihood of Approval
Pertuzumab biosimilar is under clinical development by Mabscale and currently in Phase I for Metastatic Breast Cancer. According to GlobalData,...
Data Insights
Pertuzumab biosimilar by Mabscale for Breast Cancer: Likelihood of Approval
Pertuzumab biosimilar is under clinical development by Mabscale and currently in Phase I for Breast Cancer. According to GlobalData, Phase...